ArticleResearch square2026
GenPTM: A Generalizable Framework for Protein Post-Translational Modification Information Extraction from the Scientific Literature.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Background: Protein post-translational modification (PTM) plays a pivotal role in cellular activities and biological processes. Although several databases curate PTM information, most cover only a limited number of PTMs. Although the scientific literature continues to accumulate a vast amount of PTM-related knowledge, these databases are not updated regularly. This growing information gap highlights the need for automated information extraction (IE) systems that can identify modified proteins and their specific amino acid sites directly from the literature. While numerous PTMs have been reported in scientific articles, most existing tools are designed only for a few specific PTMs, and developing separate systems for every PTM is not feasible. Methods: To address this challenge, we developed GenPTM, a generalized and adaptable IE tool that identifies modified proteins and sites from PubMed abstracts using a unified text representation strategy. GenPTM replaces PTM-specific modification and chemical group mentions with generic placeholders, allowing the model to focus on shared textual patterns that express modification events. A BiomedBERT-based classifier is fine-tuned to determine whether a candidate protein or site is truly modified, and a post-processing module assembles the final protein, site, or protein-site pair predictions. Results: Trained on five major PTM types (e.g., Ubiquitination, Phosphorylation) and evaluated on eight additional PTMs, including PTMs that are not frequently mentioned (e.g., Citrullination, AMPylation), GenPTM achieves F1-scores ranging from 92% to 96% across all PTMs for three different evaluation categories. Conclusions: These results exhibit strong generalization capability of GenPTM by providing a viable solution for PTM-agnostic IE and automated PTM knowledge discovery in proteomics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.